The decrease in the effectiveness of focus treatments is thought to be due to metabolic exhaustion or biological blockages induced by chronic stress, rather than simple tolerance, and could be corrected by targeted interventions (supplements, medication quality, or management of physiological foundations).

noli's read

The community is exploring various hypotheses to explain the drop in the efficacy of stimulant treatments, oscillating between logistical causes (variable quality of generics, cited in user reports) and metabolic ones. The idea that chronic stress activates an inhibitory response (such as the ISR pathway) is a fascinating theory derived from basic research models, but the use of molecules like ISRIB remains experimental and lacks human clinical data for this specific use (preclinical research in animal models, exploratory nature). The argument regarding neurotransmitter exhaustion (dopamine/norepinephrine) and vitamin depletion (thiamine) relies on standard biochemical logic, but often lacks evidence from clinical trials (RCT) validating their direct impact on stimulant tolerance. Conversely, the importance of hydration, regular nutrition, and rest is widely supported by research on stress physiology and cognitive function. The community is divided: it rejects the idea of a single biological inevitability in favor of a multitude of environmental, metabolic, and product-related factors.

the sources

1. 1r/Nootropics